OSTEONORM is a Polynucleotide based product in prefilled syringes (Medical Device Class III) which has been demonstrated in several clinical studies to provide long-term pain relief without systemic side effects associated with most available OA products (NSAIDS). It can be differentiated in the market as it is novel, patent protected and represents a unique value proposition and can be positioned as an efficacious product for the treatment of OA symptoms and can be considered an alternative to Hyaluronic Acid. It has been documented to reduce patients intake of NSAIDS.